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A novel sensing system based on fluorescence resonance energy transfer (FRET) between CdTe quantum dots (QDs) and Rhoda-
mine B (RB) was established for the detection of matrix metalloproteinases (MMOL/LPs). In this system, 535-nm-emitting quan-
tum dots (QDs) were bound to Rhodamine B (RB) via a MMOL/LP-specific peptide. A 76% reduction in luminescence was 
achieved because of FRET. Release of RBs by peptide cleavage restores radiative QD photoluminescence. Initial studies observed 
a 73% rise in luminescence over 60 min. The design platform of the nanosensor is flexible and can be fine-tuned for a wide array 
of applications such as the detection of biomarkers, early diagnosis of disease, and monitoring therapeutic efficacy simply by 
changing the sequence of the peptide linker. 
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Homogeneous semiconductor nanocrystals or quantum dots 
(QDs) in the 2–6 nm size range are of considerable current 
interest, not only because of their unique size-dependent 
properties, but also because of their dimensional similarities 
with biological macromolecules (e.g. proteins and nucleic 
acids) [1,2]. These similarities could allow an integration of 
nanotechnology and biology, make them potential candi-
dates as a platform for biorecognition events. The modula-
tion of QD luminescence provides the opportunity for the 
transduction of these events via fluorescence resonance en-
ergy transfer (FRET), electrochemiluminescence (ECL), 
charge transfer quenching, and bioluminescence resonance 
energy transfer (BRET) [3–5]. 
Up to now, much attention has been paid to FRET method 
for in vitro and in vivo assays of proteases due to its sim-
plicity, rapidness, sensitivity and reproducibility [6]. QDs 
are excellent donors in FRET because of their numerously 
advantageous features. First, QDs provide the opportunity 
for the interaction of a single donor with multiple acceptors 
via assembly at the QD surface. Next, since the quantum 
yield of QDs is generally high, the size-tunable photolumi-
nescence (PL) of QDs provides large donor-acceptor spec-
tral overlap integral and a possibility for maximizing the 
Förster distance. Another advantage is afforded by the 
broad absorption spectrum of QDs, which make it easier to 
work far from wavelengths associated with acceptor dye 
transitions. Furthermore, the high molar absorption coeffi-
cients and potentially high quantum yields of QDs also al-
low the use of lower intensity excitation, further minimizing 
the direct excitation of acceptors and photobleaching rates 
[7–10]. 
It is now evident that matrix metalloproteinases (MMOL/ 
LPs), as the most prominent family of proteinases associat-
ed with tumorigenesis, function more complex than modu-
lators of the tumor microenvironment [11–13]. Rather, they 
also take a role in extracellular matrix turnover and cancer 
cell migration, MMOL/LPs regulate signaling pathways that 
control cell growth, angiogenesis, or inflammol/Lation, and 
may even work in a nonproteolytic manner [14]. We de-
signed a probe that are only based on substrates might be 
2658 Li X, et al.   Chin Sci Bull   July (2013) Vol.58 No.21 
limited by their overall lack of region specificity. The pep-
tide sequence present in interstitial collagen targeted by a 
variety of proteases including MMOL/LP-2, -9, and -14, 
which can be used to detect MMOL/LP activity predomi-
nantly at the leading edges of migrating tumor cells [15]. 
This probe consists of a QD with a green fluorescence 
emission as a donor of FRET, an organic dye Rhodamine B 
(RB) as a fluorescent receptor, whith connected with a 
MMOL/LP-specific peptide [16]. It was hypothesized that 
QDs labeled activatable probes induce a higher specificity 
and sensitivity of the probe in vivo, since the nanoparticles 
can deliver the probe effectively to the disease sites (i.e. 
tumor region) by the enhanced permeation retention effect 
and because the peptide substrate-mediated fluorescence 
labeling of the QDs can be strongly quenched [17]. When 
the probe is exposed to the specific MMOL/LP of interest, 
cleavage of the substrate occurs due to specific substrate 
recognition by the MMOL/LPs; this is manifest in the form 
of a pronounced fluorescence signal recovery due to de-    
quenching of the dye (Figure 1).  
1  Materials and methods 
1.1  Materials and chemicals 
Tellurium powder, sodium borohydride, absolute ethanol, 
chloroform, isoamyl alcohol, CdCl2·2.5H2O, NaBH4, N- 
acetyl-L-cysteine (NAC), N-hydroxysuccinimide (NHS), 
1-[3-(dimethylamino)prop-yl]-3-ethylcarbodiimide-methiodide 
(EDC), penicillinsodiumhydr-oxide and sulfuric acid were 
of analytical grade. Red-free RPMI 1640 and DMEM (San-
gon Biotech, Shanghai, China). Fetal bovine serum (FBS), 
streptomycin, penicillin, trypsin-EDTA were purchased from 
Gibco (Life Technologies, Shanghai, China). MMOL/LPs- 
specific peptide linked with Rhodamine B (RB) was pur-
chased from Apetide (Chutai Bio-technology, Shanghai, 
China). Redistilled water was used in all experiments.  
1.2  Quantum dot synthesis 
NAC-stabilized CdTe quantum dots were synthesized ac-
cording to the reported method [18]. Firstly, the sodium 
hydrogen telluride (NaHTe) was prepared as follows. Under 
N2 atmosphere, NaBH4 was used to react with tellurium at a 
molar ratio of 3:1 in redistilled water/absolute ethanol. 
Subsequently, the fresh NaHTe solution was added to the  
 
Figure 1  A schematic of FRET-based MMOL/LP-2 detection method 
using QDs-peptide-RB nanoassembly. 
prepared precursor solution (n(Cd)=0.2 mmol/L, n(NAC)= 
0.8 mmol/L, pH 8.5) under vigorous stirring in N2 atmos-
phere. The feed molar ratio of Cd:Te:NAC was fixed at 
1.0:0.5:4. Then it was refluxed at 95°C. The QDs with 
different fluorescence were synthesized under different re-
fluxing time separately. The resulting CdTe QDs were pre-
cipitated with cold 2-propanol and then isolated by centrif-
ugation and decantation to remove excess Cd-NAC com-
plexes.  
1.3  Bioconjugation of QDs and peptide-RB 
QDs dissolved in deionized water (1 mg/mL) were activated 
with EDC and NHS to form an active ester leaving group. 
The N-terminus of the synthesized peptide-RB was then 
covalently linked to the QD at the active ester site to form 
an amide. Peptide activation of the C-terminus was pre-
vented by reacting residual EDC with -mercaptoethanol 
prior to peptide addition. At the coupling reaction, peptide 
was added at pH 7 in a series of feed molar ratio of QD:RB 
(1:3, 1:4, 1:5, 1:6 and 1:7) to ensure properly coupling 
onto the QD. The reaction was allowed to proceed overnight 
in the dark at room temperature. The solution was then dia-
lyzed with 3500 MWCO (Spectrum, America) cellulose 
ester membrane to remove any unreacted peptide-RB or 
byproducts. Finally, store them in 4°C refrigerator after 
freeze-drying and weighing. 
1.4  Characterization of the probe 
Dissolve the probes in deionized water (2 mg/mL). All meas-
urements were performed at pH 4.0 and room temperature 
with a 200 L quartz stoppered cuvette (Wanqing chemical 
classware instrument, Nanjing, China) to prevent evapora-
tion. Absorption and photoluminescence spectra of the solu-
tion were measured by 754-PC UV-Vis spectrophotometer 
(Jinghua Technological Instrument Corporation, Shanghai, 
China) and Lengguang F96 Fluorescence spectrophotometer 
(ex=370 nm). Transmission electron microscopy was per-
formed to investigate the morphology of CdTe QDs and 
probes alloyed on JEOL JEM-2100 electron microscopes.  
Fourier transform infrared spectroscopy (FTIR) tests 
were conducted on a Impact 410 FTIR spectrometer (Ni-
colet, America). Samples were made into films by mixing 
them with KBr. 
1.5  Preparation of enzyme solution  
Five cell lines (MCF-7, HepG2, Bel-7402, A549 and MDA- 
MB-231) were used for MMOL/LP-2 expression evaluation 
by reverse transcriptase PCR. Briefly, total RNA was ex-
tracted from freshly isolated cancer cells using Rneasy Kit. 
RNA (3 g) from each cancer cell line was converted into 
cDNA with Superscript Ⅲ reverse transcriptase. Subse-
quently, 1.0 L cDNA was used for PCR amplification with 
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MMOL/LP-2 primers (sense: 5′-GGAGCATGGCGATGG-      
ATA-3′, antisense: 5′-CAGTGGACATGGCGGTCT-3′). The 
product length was 491 bp. The product (5 L) was used for 
2% agarose gel electrophoresis. 
MDA-MB-231 breast cancer cells over-expressing MMOL/ 
LPs (MMOL/LP+) and MCF-7 breast cancer cells with low 
expression of MMOL/LPs (MMOL/LP) were used to assess 
the specificity of the probe. Each cell line was grown in 
phenol red-free DMEM and RPMI 1640 solution that in-
cluded 10% fetal bovine serum, 2 mmol/L L-gluta-     
mine and 1% penicillin-strep-tomycin under standard con-
ditions at 37°C and a humidified atmosphere containing 5% 
CO2 and 95% air for at least 18 h [19,20]. After the cell 
culture to logarithmic phase, the medium was removed and 
stored in 4°C refrigerator. 
1.6  Activation of the probe  
QD probe was added to the MDA-MB-231 medium solution 
at a final concentration of 0.8, 1, 1.2, 1.4, 1.6, 1.8, 2 mg/mL 
and stirred for 2 h. Time-integrated photoluminescence was 
measured before and after cleavage of the probe to observe 
recovery of RB at pH 4. Control samples (QD probe with 
MCF-7 medium solution at a concentration of 2 mg/mL) 
were monitored simultaneously. 
2  Results and discussion 
2.1  Confirmation of the FRET system 
Under optimized conditions, the fluorescence spectra of CdTe 
QDs were tunable in the range of 525–650 nm by changing 
the refluxing time. The QDs refluxed 69 min with emission 
maximum at 535 were used in the present study. And their 
quantum yields were measured to be 63%–70% . 
Fluorescent material acted as the donor and receptor 
needs to meet some certain conditions before they can pro-
duce FRET, such as the distance must be less than 10 nm, a 
dipole relative orientation, and the most important, the do-
nor fluorescence emission and absorption of the receptor 
have a large overlap [6]. Although a variety of organic dyes 
can be used as a FRET fluorescent donor-receptor pairs, we 
contact RB and QD by the peptide at each end, so that it 
satisfies the conditions of less than 10 nm. Figure 2 shows 
that the emission of QDs overlaps well with the absorption 
of RB labeled peptides, and their emission spectra overlap 
very little, suggesting an efficient FRET between them. 
We further analyzed the UV absorption of the FRET 
probe (Figure 3). The absorption spectral of RB-coupled 
peptides showed the characteristic absorption peaks, which 
could be used for RB (555 nm). As QDs have a wide range 
of 250–500 nm UV absorption which overlap with original 
peptide-RB, there was only an increase from 250 to 500 nm 
observed at the absorption spectral of QD probe, but not the 
characteristic peaks of QDs. And the characteristic absorption  
 
Figure 2  UV-Vis absorption and fluorescence emission spectra of NAC- 
capped QDs and RB. 
 
Figure 3  UV-Vis absorption spectral of peptide-RB and QDs-peptide- 
RB UV-Vis absorption spectral of the FRET-based probes. 
peaks could be used for confirming peptides (280 nm). Be-
cause of the dialysis of small molecular (peptide-RB), we 
could determine the peptide-RB ultimately connected with 
the quantum dots. 
FTIR spectroscopy is helpful to confirming the conjuga-
tion of CdTe QD to peptide. In Figure 4, the FTIR spectra 
of NAC-capped CdTe QDs show a peak at 3443 cm1, this 
particular band can be assigned to –OH and –NH stretching 
mode of NAC. The peaks at 1208 and 1140 cm1 corre-
spond to the stretching vibration of C–N. The narrower peak 
at 1682 cm1 is typical of C=O, and the observed shift could 
be due to the coordination of the Cd atoms present on the 
surface of CdTe QDs. 
Figure 5 describes the FTIR spectra of QD-peptide-RB. 
It can be noticed that there is a broad absorption peak at 
3396 cm1, characteristic of the stretch vibration of O–H as 
well as N–H. The peaks at 1598 and 1290 cm1 are assigned 
to CONH–, resulting from the conjugation of QD and pep-
tide. While the band at 1395 cm1, more than likely the 
overlap of two individual peaks, is ascribed to the symmol/ 
Letrical deformation of CH2 and CH3 come from the peptide. 
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Figure 4  FTIR spectra of QDs. 
 
Figure 5  FTIR spectra of QD-peptide-RB. 
2.2  Optical properties of QDs probe 
Figure 6 depicts the fluorescence of the RBs that was stim-
ulated by QDs through FRET. Activated ester solution was 
added to the reaction system with different contents of QDs. 
As a result, RB fluorescence gradually increased with the 
increase of the the reaction feed ratio of QDs. Spectroscopic 
analysis of the QD-functionalized RB indicated that ap-
proximately 6 units of RB associated with each particle 
were the most effective. Further increase in the QDs acti-
vated ester decreased the FRET efficiency. This may be due 
to an excessive number of QDs not connected with the pep-
tide, which cannot yield RB energy transfer phenomenon, 
but need excitation energy to stimulate, resulting in reduc-
tion of QDs fluorescence intensity using for FRET. As the 
pH of solution was acid, the characteristic peaks of QDs at 
535 nm was not shown [21]. But as soon as the pH was ad-
justed to 8, fluorescence of the QDs occurred. Figure 7, 
which depicts the luminescence of the QDs stimulated by 
RBs through FRET, proves the same reaction ratio.  
QD-peptide-RB luminescence performed a 76% exaltation 
of signal compared to unreacted peptide-RB (Figure 8). It  
 
Figure 6  Fluorescence spectra of QD-peptide-RB probes with different 
feed molar ratio of QD:RB.  
 
Figure 7  Fluorescence spectra of QD-peptide-RB probes with different 
feed molar ratio of QD:RB.  
was obvious that QD and RB were within a short distance 
linked by the peptide, which induced an efficient energy 
transfer and consequently resulted in the fluorescence stim-
ulating of the RB. 
2.3  Morphological characterization  
Transmission electron microscopy (TEM) was used to in-
vestigate the morphology and crystal structure of CdTe QDs 
and QD probes. Figure 9(c) shows a low-magnification TEM 
image of the prepared QDs, indicating that these nanocrys-
tals were close to spherical with excellent polydisperisity 
and average size was about 3.5 nm. The average size of QD 
probes was 3.8 nm (Figure 9(a)) which implied some con-
nection with substrates. Further analysis of the crystalline 
structures was performed by high-resolution TEM images 
(Figure 9(b),(d)). QDs presented clear intact crystal lattice 
lines, and their crystal structures could be attributed to the 
cubic (zinc blende) phase consistent. Thus, the structure of 
QDs did not change after the bioconjugation.  
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Figure 8  This chart demonstrates the exaltation in peptide-RB lumines-
cence after covalent bonding of QDs. Fluorescence intensity at 585 nm was 
measured.  
 
Figure 9  Low-magnification TEM image (a) and HR-TEM image (b) of 
CdTe QDs with PL emission peak at 535 nm; low-magnification TEM 
image (c) and HR-TEM image (d) of QD-peptide-RB probes.  
2.4  Fluorescence recovery of QDs 
Figure 10 shows the expression of MMOL/LP-2 in a num-
ber of cells. Real-time PCR analysis revealed that the 
MMOL/LP-2 mRNA expression was markedly different in 
cells, a high level expression was observed in MDA-MB- 
231; low level in MCF-7, HepG2, Bel-7402 and A549, 
which previous findings have indicated. 
Since MMOL/LPs were enzyme of secretory, they would 
exist in the medium if expressed. Luminescence of each 
sample in the activation of the probe was measured at the 
following time points: 0, 10, 20, 30, 40 and 60 min. Figure 
11 illustrates the spectral profile of reduced RB lumines-
cence over time. And there was very little autofluorescence 
at 585 nm from enzyme solution. A reduction in lumines-
cence over time of the probe with MMOL/LPs was observed 
in Figure 12. At 60 min, an average luminescence lower of 
73% was performed. The control group containing inacti-     
 
Figure 10  RT-PCR screening of MMOL/LP-2 present in five diffrernt 
cells. M, DNA marker; 1, MCF-7; 2, HepG2; 3, Bel-7402; 4, A549; 5, 
MDA-MB-231. 
 
Figure 11  Plot of probes activation with MMOL/LP+(MDA-MB-231 
medium) solution and MMOL/LP-(MCF-7 medium) solution increased 
luminescence over time. 
 
Figure 12  This chart demonstrates the reduction of the probe reacting with 
MMOL/LP enzyme solution. Fluorescence intensity at 585 nm was measured.  
vated probe (probes within MCF-7 solution) indicated sta-
tistically insignificant changes in luminescence during the 
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same time intervals. 
Preliminary results demonstrate proof-of-principle that 
the QD-peptide-RB probes were highly promising agents not 
only for extending the limits of optical imaging by provid-
ing an inherent increase in the signal: background ratio, but 
also for monitoring protease activity which may provide 
information about the metastatic potential of a tumor. 
3  Conclusion 
On the basis of the above results, FRET between the CdTe 
QD and RB was successfully applied in sensing MMOL/ 
LPs with specific cleavage. When activated, a quenching of 
QD and an excitation of RB happened to the probe. With 
the further studies in the biology field, the donor-acceptor 
pair of QD and RB will exhibit more utilities and features in 
design of assays systems based on their interaction. Several 
parameters need further optimization for the advancement 
of clinically applicable QD protease probes, like inherent 
biocompatibility and the acceptor valence. An important 
issue in proteolytic activity is peptide accessibility, which is 
affected by interparticle distance between the QD and RB, 
the density of peptide-RB surrounding the QD. All of these 
parameters will be individually characterized to tailor reac-
tion rates of proteolytic activation in future studies. 
Current fluorescent imaging agents provide the increased 
contrast by accumulation of fluorophores with specific tar-
gets of interest. These agents supply limited functionality in 
the ability to observe molecular specific processes. Devel-
oping smart optical contrast agents that respond to molecu-
lar processes, for example protease activity, is pressing. The 
QD probe not only provides the advantages of observing 
time- or spatial-dependent processes, but also ensures an 
inherent increase in signal:background ratio greater than 
conventional targeted fluorophores. This nanosensor is 
flexible and can be fine-tuned for a wide array of applica-
tions such as early diagnosis of disease, the detection of 
biomarkers, and monitoring therapeutic efficacy simply by 
changing the sequence of the peptide linker. Future studies 
will be committed to optimizing and enhancing the quench-
ing and unquenching efficiency of these smart probes. 
Moreover, due to the narrow emission bandwidth of QDs, it 
is potential to construct a library of different wavelength 
emitting biocompatible quenched probes, each with its own 
enzyme specificity and acceptor pair to allow for simulta-
neous imaging from many different proteases.  
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